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ABSTRACT
Motivation: Exome sequencing has proven to be an effective tool to
discover the genetic basis of Mendelian disorders. It is well estab-
lished that copy number variants (CNVs) contribute to the etiology of
these disorders. However, calling CNVs from exome sequence data is
challenging. A typical read depth strategy consists of using another
sample (or a combination of samples) as a reference to control for the
variability at the capture and sequencing steps. However, technical
variability between samples complicates the analysis and can create
spurious CNV calls.
Results: Here, we introduce ExomeDepth, a new CNV calling algo-
rithm designed to control for this technical variability. ExomeDepth
uses a robust model for the read count data and uses this model to
build an optimized reference set in order to maximize the power to
detect CNVs. As a result, ExomeDepth is effective across a wider
range of exome datasets than the previously existing tools, even for
small (e.g. one to two exons) and heterozygous deletions. We used
this new approach to analyse exome data from 24 patients with pri-
mary immunodeficiencies. Depending on data quality and the exact
target region, we find between 170 and 250 exonic CNV calls per
sample. Our analysis identified two novel causative deletions in the
genes GATA2 and DOCK8.
Availability: The code used in this analysis has been implemented into
an R package called ExomeDepth and is available at the Comprehen-
sive R Archive Network (CRAN).
Contact: v.plagnol@ucl.ac.uk
Supplementary Information: Supplementary data are available at
Bioinformatics online.
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1 INTRODUCTION
The improvement of DNA sequencing technologies in recent
years has radically changed the identification of genetic variants
associated with human diseases and in particular, rare disorders
(Ng et al., 2010). The use of sequence capture technologies to
target protein-coding regions in the human genome followed by
high-throughput DNA sequencing (known as exome sequencing)
currently provides a cost-efficient approach to discover causal
mutations in patients with Mendelian disorders. The majority
of published work using exome sequence data focuses on single
nucleotide polymorphisms (SNPs) or small insertions/deletions
(indels), mostly because short read DNA sequencing technolo-
gies are best suited to call these variants. Nevertheless, copy
number variants (CNVs), e.g. larger chromosomal indels, also
significantly contribute to the aetiology of Mendelian disorders.
Three general strategies exist to call CNVs from short read
sequence data (Medvedev et al., 2009): split reads (Karakoc
et al., 2011; Ye et al., 2009), paired-end reads (Zeitouni
et al., 2010) and read depth approaches (Krumm et al., 2012;
Sathirapongsasuti et al., 2011; Xie and Tammi, 2009). Read
depth analysis is particularly effective for exome data as it does
not rely on sequencing into or near the CNV breakpoints.
Generally speaking, read depth-based approaches for CNV call-
ing compare the number of reads mapping to a chromosome
window with its expectation under a statistical model.
Deviations from this expectation are indicative of CNV calls.
Similar to the array comparative genomic hybridization
(aCGH) methodology, the ratio of read count between a test
and a reference sample is usually preferred to a single-sample
analysis in order to control for the typically extensive variability
in capture efficiency across exons (Krumm et al., 2012;
Sathirapongsasuti et al., 2011; Xie and Tammi, 2009). Most of
the existing tools for CNV calling that are based on read depth,
such as ExomeCNV (Sathirapongsasuti et al., 2011) and
CNV-seq (Xie and Tammi, 2009), make Gaussian assumptions
about the distribution of read count ratio. In the absence of
technical variability, the proportion of reads matching to a spe-
cific sample should follow a binomial distribution whose success
rate is determined by genome-wide read count ratio between the
test sample and the reference set, as well as the potential presence
of CNVs. Additional covariates, such as GC content, can alter
this success rate in situations where the effects of these covariates
vary across samples (Marioni et al., 2007).
Here, we evaluate two different exome sequence datasets and
show that Gaussian assumptions generally do not hold. Techni-
cal variability at the library preparation, capture and sequencing
creates noise that affects the numbers of reads matching to*To whom correspondence should be addressed.
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particular exons in a sample-specific manner. As a result, the
observed variance exceeds what is predicted by a binomial
model that affects the CNV calls. Motivated by this observation,
we propose a modified and more robust statistical framework for
CNV calling. We apply this model to provide guidelines for the
construction of an optimized reference sequence dataset for CNV
calling purposes, as well as realistic power estimates. We find
that two main factors improve statistical power: increasing the
read depth and controlling for any source of technical variability
across samples at the capture and sequencing steps. We have
developed and coded a new set of tools in an R package called
ExomeDepth. We then illustrated its efficiency by discovering
novel small causative CNVs in two patients with primary immu-
nodeficiencies, a heterozygous deletion of two exons of the
GATA2 gene and a single-exon homozygous deletion in the
DOCK8 gene.
2 SYSTEM AND METHODS
2.1 Fitting a robust beta-binomial model for the read
depth data
We analysed the read count data for 24 exome samples from
primary immunodeficiency patients (divided into two datasets,
Supplementary Table S1 and Section 3). An overview of a nor-
malized measure of read depth [matching fragments per million
reads and per kilobase, FPKM, (Mortazavi et al., 2008), Fig. 1A]
showed extensive exon–exon variability. Inference of CNV status
can therefore, not rely on the highly variable single-sample read
count data. However, a comparison between pairs of exome
datasets (Fig. 1A) demonstrates the high level of correlations
of the normalized read count data across samples (squared
FPKM correlation coefficients 0.98–0.988 among 15 exomes in
Dataset 1 and 0.72–0.987 for the 9 exomes in Dataset 2). It is
therefore possible to use one exome or combine several exomes
to construct a reference set to base the CNV inference on.
Initially, we analysed pairs of exomes and fitted a binomial
model to the genome-wide distribution of read depth data for
the reference and the test sample (see Section 3). For the purpose
of parameter estimation (but not for subsequent CNV calling
steps), we removed exons located in regions harbouring
common CNVs (Conrad et al., 2010) to limit the possibility
that copy number variable regions increase the variance of the
read count ratio. The outcomes of two representative compari-
sons between a pair of exomes from Dataset 1 and a pair of
exomes from Dataset 2 are shown in Figure 1B and C, respect-
ively. The larger variance observed in Figure 1C compared with
1B illustrates that the outcome of this analysis varies extensively,
depending on how sequencing and capture were conducted.
The larger variance observed in Figure 1C compared with 1B
illustrates that the outcome of this analysis varies extensively
depending on how sequencing and capture were conducted. To
quantify the variability between B and C, we defined the statistic
Rs as the ratio between the standard errors of the beta-binomial
model and the binomial model (Section 3). This statistic can be
intuitively understood as the ratio between the typical distances
separating the blue and red curves in Figure 1B and C.
Our results show that a binomial model fails to properly cap-
ture the extensive variability in read count ratio across samples.
Even in the best case scenario of two well-matched exomes (red
line in Fig. 1B), 6.8% of the exons were located outside of the
99% confidence interval. When two exomes were poorly
matched (red line in Fig. 1C), a total of 23.2% of exons were
outside of the 99% confidence interval. We therefore modified
this binomial model and fitted instead a beta-binomial distribu-
tion (seeSection 3) to account for the over-dispersion in read
count ratio. We further modified the model to account for
observed correlations between depth of sequencing and the
over-dispersion parameter (Supplementary Fig. S1). This
beta-binomial model significantly improved the fit (blue line in
Fig. 1B and C). The proportion of exons outside of the 99%
confidence interval was reduced to 1.8% for the well-matched
pair of exomes and to 2.3% for the poorly matched pair (blue
lines in Fig. 1B and C, respectively) To quantify this noise in the
sequence data, we defined the statistic Rs as the ratio between the
standard errors of the beta-binomial model and the binomial
model. This statistic can be intuitively understood as the ratio
between the typical distances separating the blue and red curves
in Figure 1B and C. For each sample in Datasets 1 and 2, we
estimated the optimum reference set (see below for a description
of this procedure) and computed the Rs statistic. For Dataset 1
typical values of Rs varied between 1.5 and 2, depending on the
sample, with an average value of 1.62. For Dataset 2,
typical values of Rs varied between 2 and 4.5 (average: 2.76).
Fig. 1. (A) Comparison of fragment per kilobase and million base pairs
(FPKM) between two exomes (FPKM squared correlation coeffi-
cient¼ 0.992). (B) Total read depth for two typical well-matched
exomes (y-axis) as a function of the proportion of reads mapping to
one of two exomes (x-axis). The red lines show the 99% confidence inter-
val assuming the best fitting binomial distribution for the read count
data. The blue lines show the same 99% confidence interval assuming
the best fitting beta-binomial robust model for the same dataset.
(C) Same as (B) but for two typical exomes that are poorly matched to
each other. (D) Rs statistic (x-axis) and correlation between FPKM
values (y-axis), both of them computed for each exome with its associated
reference set
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The Rs statistic measures the correlations across samples and can
be well approximated using the squared pairwise correlation co-
efficient of FPKM values between the test sample and its asso-
ciated reference set (Fig. 1D). We hypothesized that some of the
differences between samples might be explained by a differential
effect of the DNA sequence GC content on capture and sequen-
cing efficiency. Therefore, in the regression analysis, we added
GC content as a percentage. The noise reduction was consistent
but relatively limited: in Dataset 1, the average Rs decreased
from 1.62 to 1.59. In Dataset 2 the average Rs decreased from
2.76 to 2.45.
2.2 Power study and optimization of the reference
exome set
The different levels of noise illustrated in Figure 1B and C have
large implications for the power to detect CNVs. We used a
single-exon heterozygous deletion as a typical CNV and esti-
mated the expected value of the posterior probability for this
heterozygous deletion given different sets of parameters. We con-
sidered three scenarios: Rs¼ 1 (absence of any technical bias),
Rs¼ 1.6 (typical of Dataset 1) and Rs¼ 2.5 (typical of Dataset 2).
The construction of the optimum reference set is coded in the
select.reference.set function of the ExomeDepth package. To
summarize briefly, for each test exome we rank the remaining
samples by order of correlation with the test exome. Samples are
then added sequentially to the aggregate reference set. At each
iteration we fit our robust model and compute the expected value
of the posterior probability in favour of a single-exon heterozy-
gous deletion call. This process of adding samples to the aggre-
gate reference stops once the posterior probability stops to
increase. This optimization is essentially a trade-off between lim-
iting the variance (by increasing the size of the reference set) and
increasing the bias (by adding exome samples to the reference in
spite of being less correlated). In Dataset 1 (Fig. 2A) we found
that the optimum size of the reference set was 10. In several
instances adding further samples in the reference set actually
decreased the power.
Figure 2B investigates the role of read depth on the power to
detect a CNV. For Datasets 1 and 2, we selected the optimum
reference sets and extracted the parameters associated with this
fit. We investigated the effect of read depth by changing the
expected number of reads that map to the heterozygous deleted
exon in the test sample. In contrast with Figure 2A, this compu-
tation holds the Rs parameter constant, i.e. we assume that all
additional exome samples are similarly correlated with the test
exome. It therefore only considers the role of read depth and not
the added complexity of adding exome samples that are not
necessarily as well correlated with the test exome. This analysis
showed strong differences between Datasets 1 and 2. In Dataset
1, 300 reads mapping to an exon in the test sample were sufficient
to provide complete power, whereas for Dataset 2, the posterior
probability in favour of the deletion call could never exceed 30%,
even with more than 500 reads. This result indicates that an
increase in the read depth cannot compensate for low levels of
correlations between the exomes. Using 100-bp paired-end reads,
and assuming a 500-bp long exon, 300 mapping reads amount to
an average read depth of100. This read depth would need to be
twice larger (i.e. 200) if the exon was only 250-bp long. To
provide a more general boundary for the size of the reference
set, we investigated in Figure 2C and D the behaviour of the
power estimates as the size of the reference set increases. As
for Figure 2B, we used the optimum parameters estimated in
Figure 2A for the median samples in Datasets 1 and 2 and
kept the Rs parameter constant. Hence, no bias is created by
adding less correlated exome samples and only the effect of the
size of the reference set is evaluated. We considered two scenarios
of moderate and high read depth (Fig. 2C and D). With these
assumptions, while the power keeps increasing, the increase be-
comes slow once the reference:test ratio reaches a value of 10.
This result suggests that very large reference sets would provide
only limited increase in power to detect heterozygous deletions.
In all tested scenarios, the difference between the power curves
estimated from the bias-free model (black line in Fig. 2B–D)
compared with the estimates in either of the datasets (red and
blue lines) was large. Datasets 1 and 2 also showed substantial
difference in power (Fig. 2C and D). These observations
A B
C D
Fig. 2. Power study showing the expected posterior probability for a
heterozygous deletion call. (A) Expected value of the posterior probability
(averaged over all exons) for the 15 exomes in Dataset 1 as a function of
the (test:reference) read count ratio (which is closely approximated by the
number of exomes in the aggregate reference set). Each line shows a
different test exome sample and the most correlated exome is added to
the reference at each step. (B) The expected number of reads that would
be mapping to a normal copy number exon varies (along the x-axis) but
the (reference:test) sequencing depth remains constant at 10 (i.e. the ref-
erence set approximately consists of an aggregate of 10 exomes). Other
parameters, including the level of correlations between test and reference
exome, are kept constant. Power estimates assume a typical exome from
each of the two Datasets 1 and 2 (the median value of the posterior
probability is shown). (C), (D) The number of exomes in the aggregate
reference set varies but the expected number of reads mapping to a
normal copy number exon for the test sample is set to 100 (C) and 200
(D). For (B), (C) and (D), the black line refers to an optimum dataset in
the absence of sample-to-sample technical variability (Rs ¼ 1), longer
dash to the typical dispersion parameter estimated from Dataset 1
(Rs¼ 1.6) and shorter dash for the typical dispersion parameter estimated
from Dataset 2 (Rs¼ 2.5)
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illustrate an important effect of variability between individual
exomes in a dataset, which is captured by the Rs statistic, on
the power to detect CNVs. Note that the power to detect
single-exon heterozygous deletions in Dataset 2 remains very
low and would not reach 1 in any realistic scenario, because
the level of noise is too high. Therefore, in Dataset 2 CNVs
need to overlap multiple exons to be detectable. Power estimates
for heterozygous duplications were much lower than for hetero-
zygous deletions (Supplementary Fig. S2), a difference also com-
monly observed for all array-based CNV assays. Both datasets
lacked power to detect single-exon heterozygous duplications
(Supplementary Fig. S2A–D), but larger duplications could be
identified. For example, in Dataset 1, and to some extent in
Dataset 2, a three-exon heterozygous duplication typically can
be detected (Supplementary Fig. S2E–H). Homozygous deletions
are naturally easier to detect than heterozygous deletions.
Although quantifying the power is complicated by the arbitrary
parameterization of the background level of mapping reads, we
found that under most realistic assumptions, an expected number
of reads greater than 30 mapping to an exon in the test sample
was sufficient to identify a homozygous deletion in either of the
two datasets.
2.3 Characteristics of CNVs and comparison with
other tools
The probability for the hidden Markov chain to enter a cn 6¼ 2
state sets the sensitivity/specificity balance of ExomeDepth. We
parameterized this value using the expected number of CNV calls
for an exome sequence (Section 3 and Supplementary Fig. S3).
We found the total number of CNV calls to be relatively stable
over the range of parameters considered (Supplementary
Fig. S3), only increasing sharply for a prior expectation of
1000 CNV calls genome-wide. The ExomeDepth default param-
eter uses a relatively stringent prior expectation of 20 CNV calls
per exome sequence. With this choice, ExomeDepth called a
median number of 213 CNVs per sample in Dataset 1, including
62.3% deletions. Consistent with the more limited power in
Dataset 2, ExomeDepth identified a lower median number of
177 CNV calls in this dataset (62.9% of them deletions), in
spite of a 31.5% larger target region (50Mb versus 38Mb).
CNVs called by ExomeDepth in Datasets 1 and 2 included a
median number of five exons and a median length of 10.6 kb.
About 10% of the CNV calls were longer than 100kb and 0.1%
were longer than 500kb.
Comparison with other algorithms is complicated by the ab-
sence of a ‘gold standard’ dataset and the bias inherent to CNV
calls in available CNV databases. Nevertheless, the majority of
CNVs called in our data should be present in a large-scale data-
base such as the Database of Genomic Variants (DGV), (Zhang
et al., 2006). We defined a CNV as previously reported in DGV if
a CNV listed in DGV overlaps more than 50% of our CNV call
(after excluding DGV CNV calls larger than 500kb). We found
that 13.5% of CNVs in Dataset 1 (20% respectively in Dataset 2)
were absent from DGV (Table 1).
To estimate the false negative rate, we used an additional
dataset of 12 high-depth exome samples (1000 Genomes
Project) for which an independent experiment generated CNV
calls using a high-density Nimblegen CGH array [(Conrad
et al., 2010) and Section 3]. Combining all 12 samples, the
aCGH experiment identified 1344 exonic CNV calls (303
unique calls). Conrad et al. (2010) estimate that 40% of CNVs
can be genotyped with their experimental design that translates
into an approximate expected number of 280 exonic CNV calls
per sample, which is broadly consistent with our findings.
To compare our algorithm with existing tools, we first tested
ExomeCNV (Sathirapongsasuti et al., 2011). Its underlying
model assumes that the distribution of read count ratio between
the test and reference exome is Gaussian and a similar assump-
tion is made by CNV-Seq (Xie and Tammi, 2009). Second, we
tested exomeCopy (Love et al., 2011), which uses a negative bi-
nomial model that is related to our beta-binomial approach. In
each case, we followed the methods suggested by these publica-
tions and we used the suggested default parameters. Venn dia-
grams summarizing the overlap between calling algorithms are
shown in Supplementary Figure S4.
Comparison between these three tools using a dataset of 12
exomes from 1000 Genomes and the two datasets from this study
highlighted a clear trend. First, ExomeDepth is more conserva-
tive than the other tools, with the median number of CNV calls
between 177 and 246 per exome, whereas exomeCopy and
ExomeCNV called numerous additional CNVs (Table 1 and
Supplementary Fig. S4). Second, ExomeDepth detected 75.2%
of the known exonic CNVs in the 12 exome samples from the
1000 Genomes Project (CNVs identified by the independent
aCGH experiment). This was markedly higher than the fraction
of CNVs identified by exomeCopy (52.8%) and ExomeCNV
(41.2%; Table 1), indicating a higher sensitivity. Interestingly,
the difference between our analysis and exomeCopy was more
limited for Dataset 1, for which the exomes are better matched to
each other, than for Dataset 2 and the 1000 Genomes dataset,
consistent with the fact that the aggregate reference optimization
Table 1. Comparison between our package (ExomeDepth) and two other
tools: exomeCopy and ExomeCNV
exomeDepth exomeCopy exomeCNV
Dataset 1 (n¼ 15)
Median nb of CNVs 213 495 2256
Percentage in DGV 86.5 67.8 16.3
Median CNV size (kb) 8.9 1.83 0.16
Median CNV size (exons) 5 3 1
Dataset 2 (n¼ 9)
Median nb of CNVs 177 1228 11 046
Percentage in DGV 80 36.9 26.6
Median CNV size (kb) 12.2 10.04 0.26
Median CNV size (exons) 5 5 1
1000 Genomes (n¼ 12)
Median nb of CNVs 246 641 5261
Percentage in DGV 66 37.2 34.2
Median CNV size (kb) 1.7 9.75 0.34
Median CNV size (exons) 3 4 1
Percentage of known
CNVs found 75.2 52.8 41.2
We define a CNV called from exome data as ‘in DGV’ (or a ‘known CNV’ in
the 1000 Genome analysis) when the CNV in the database overlaps450% of our
CNV call.
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step implemented in ExomeDepth is more helpful when the vari-
ability across samples is larger.
2.4 Discovery of two novel and likely disease-causing
deletions in the GATA2 and DOCK8 genes in
patients with primary immunodeficiency
We then investigated if any of the newly discovered rare CNVs in
our data affects genes that previously have been involved in pri-
mary immunodeficiencies. In patient P1 ExomeDepth identified
a heterozygous deletion of the consecutive exons 6 and 7 of the
GATA2 gene with a read count ratio50.5% quantile (Fig. 3A).
Independently, each exon would yield a posterior probability for
the deletion call of 77% (exon 7) and 15% (exon 6). The com-
bined CNV call has a posterior probability499.9%. We then
designed a custom CGH array (Supplementary Data) containing
26 probes in the GATA2 gene region. In this patient we validated
a heterozygous deletion of 6 kb that included GATA2 exons 6
and 7 (Fig. 3B). We then amplified the breakpoint region,
sequenced it and mapped the exact boundaries of this 5797-bp
deletion (Fig. 3C; coordinates chr3: 128, 196, 444-128, 202, 240).
The clinical presentation for this patient was consistent with pre-
vious reports of heterozygous variants in the GATA2 gene
(Ostergaard et al., 2011), indicating that this two exons deletion
is very likely to be causal for P1 (Supplementary Data for clinical
details).
In another patient (P2), ExomeDepth identified a deletion of a
single exon 8 of the DOCK8 gene (Supplementary Fig. S5A).
This CNV call had a posterior probability499.99%. Complete
absence of reads mapping to exon 8 is indicative of a homozy-
gous deletion. We sequenced the deletion breakpoints and iden-
tified the exact boundaries of a 3197-bp deletion (Supplementary
Fig. S5B; coordinates chr9: 323, 591–326, 787). The clinical pres-
entation is consistent with previous reports involving homozy-
gous mutations in the DOCK8 (Zhang et al., 2009) indicating
that this variant is almost certainly causal (Supplementary Data
for clinical details).
3 IMPLEMENTATION
3.1 Primary immunodeficiency patients
We investigated 24 patients who suffered from severe and/or
disseminated recurrent infections, and have been diagnosed
with primary immunodeficiencies (PIDs). Of these patients, 13
were of European descent and 11 patients were of Asian descent,
of which, 5 originated from consanguineous families. All mater-
ial from patients was obtained with informed consent from
adults and from the parents of children who participated in the
study in accordance with the Declaration of Helsinki and with
approval from the ethics committees (04/Q0501/119, amendment
2; 06/Q0508/16 and 10/H0906/22).
3.2 Exome data
We isolated DNA samples from blood or peripheral blood
mononuclear cells (PBMCs). Exome sequence data have been
generated in two batches. Dataset 1 comprises exomes from 15
patients and Dataset 2 comprises exomes from 9 patients. For
exome target enrichment Agilent SureSelect 38Mb and 50Mb
kits have been used for samples in Datasets 1 and 2, respectively.
Samples in both datasets have been sequenced using Illumina
HiSeq with 94-bp paired-end reads. Reads were aligned to the
hg19 reference sequence using the software novoalign (www
.novocraft.com). Single sample summary statistics are provided
in Supplementary Table S1.
A
B
C
Fig. 3. (A) Heterozygous deletion of exons 6 and 7 of the GATA2 gene
identified by ExomeDepth in the exome sequence data. The red crosses
show the ratio of observed/expected number of reads for the test sample.
The grey shaded region shows the estimated 99% confidence interval for
this observed ratio in the absence of CNV call. The presence of two
contiguous exons with read count ratio located outside of the condfidence
interval is indicative of a heterozygous deletion in this sample.
Independently, each exon would yield a posterior probability for the
deletion call of 15% (exon 6) and 77% (exon 7). The combined CNV
call has a posterior probability499.9%. (B) Validation of a 6-kb deletion
using a targeted array CGH (Agilent 15K format) containing 26
probes in the GATA2 gene region. Each cross indicates a probe and
red crosses indicate probes located in the region of a heterozygous dele-
tion. (C) Sequencing of the deletion breakpoints identified the exact
boundaries of this 5797-bp deletion overlapping exons 6 and 7 of the
GATA2 gene
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3.3 Read count computation
Exon locations were defined using the Ensemble database release
version 57 (human genome build hg19). We only considered
autosomal chromosomes (chr1–22) to avoid the additional com-
plication of gender (in which case, male and female samples
would need to be analysed separately). Analysis of the GC con-
tent for each exon uses the same Ensembl release and the Perl
Ensembl API tool. We used the R package Rsamtools to extract
the read count information from the individual BAM files. All
reads were paired-end. We only included consistent paired reads
(i.e. both reads located51000bp away from each other and in
the correct orientation) and with Phred scaled mapping quality
20. The location was defined by the middle location between
the extreme ends of both paired reads. Exons closer than 50bp
were merged into a single location owing to the inability to prop-
erly separate reads mapping to either of them. After merging
close exons, we considered a total number of 229 056 autosomal
exons.
3.4 Statistical model
We denote the exonic read count X for the test sample and Y for
the aggregate reference. Assuming that the distribution of the
read count ratio X=ðXþ YÞ is only determined by the relative
read depth of the test and reference samples, an appropriate
model is binomial with the probability that a random read is
assigned to the test sample is:
logitðiÞ ¼ þ i þ GC ð1Þ
where i ¼ E½Xi=ðXi þ YiÞ is the probability that a random read
belongs to the test sample (rather than the reference). The inter-
cept parameter  is estimated separately for each test sample. GC
refers to the GC content. The index i denotes the exon and the
covariate i relates to the copy number status for the exon i: the
proportion of reads mapping to the test sample for deletions/
duplications is computed based on the expected proportion for
normal copy number and assuming a read ratio of 0.5 (for a
deletion) or 1.5 (for a duplication). A motivation for our work
is the fact that this binomial model does not fully capture sample
specific biases. We propose instead the robust beta-binomial
model (Agresti, 2002):
i  Betaði, ’=1 ’Þ ð2Þ
Xi  Binomialðp ¼ i, n ¼ Xi þ YiÞ ð3Þ
where the over-dispersion parameter ’ is numerically estimated
from the read count data. Assuming this model, the mean value
of the beta binomial variable X remains unchanged but its vari-
ance becomes varðXiÞ ¼ niið1 iÞ½1þ ðni  1Þ’ where
ni ¼ Xi þ Yi, adding to the binomial variance an additional
over-dispersion term. Last, the addition of GC content to the
model contributes to predicting individual specific biases.
However, an analysis of the data showed that a single ’ typ-
ically could not fully summarize the read count variance over the
full range of read depth (Supplementary Fig. S1). We therefore,
modified the model to allow the parameter ’ to take different
values depending on the total read count. We used a linear ex-
trapolation to combine these estimates over the full range of read
depth. The number of intervals for the read count data is set to
two by default and can be modified by the user. Supplementary
Figure S1 describes this fitting process in more details.
3.5 Numerical estimation
We fitted the binomial logistic model described in Equation (1)
using the glm function in R. We fitted the beta-binomial model
described in Equations (2) and (3), including the maximum like-
lihood estimation of the over-dispersion parameter ’, using a
maximum likelihood approach implemented in the R package
aod. The procedure estimates for each exon, an expected read
ratio i and a genome-wide over-dispersion parameter ’. This
parameter estimation is done assuming cn¼ 2 for all exons. In a
second step, and for each exon, covariates for deletions/duplica-
tions are added to estimate the likelihood of the read count data
for the scenarios cn¼ 1 and 3. In the beta-binomial models ex-
pressed in Equations (2) and (3), the beta-binomial distribution is
usually parameterized using two parameters a and b [mean
a=ðaþ bÞ and variance ab=ðaþ bÞ2ðaþ bþ 1Þ]. The regression
formulation of the model described above links to this distribu-
tion with ai ¼ ið1 ’Þ=’ and bi ¼ ð1 iÞð1 ’Þ=’. Prior to
fitting these models (Fig. 1B and C), we removed exons located
in regions harbouring common CNVs (Conrad et al., 2010) to
limit the possibility that such CNVs significantly increase the
variance of the read count ratio.
3.6 Hidden Markov chain and choice of prior probabilities
For each exon, our beta-binomial model generates a likelihood
value under three distinct scenarios (copy number¼ deletion,
normal, duplication). To combine the likelihood across multiple
exons we used a hidden Markov model. Each step of the hidden
Markov state corresponds to one exon in the human genome.
This model serves the double purpose of merging CNV calls
across exons, as well as specifying a prior probability of obser-
ving a CNV for each exon. This prior probability is coded into
the transition probability of the hidden Markov chain between
the normal copy number state (cn¼ 2) and either of the copy
number variable states (cn¼ 1 or cn¼ 3). We parameterized this
before using the expected number ne of CNVs a-priori, i.e. the
probability of transitioning from cn¼ 2 to cn¼ 1 or cn¼ 3 is
P ¼ ne=n where n¼ 229 056 is the total number of exons. We
set the default model such that, from the hidden state cn¼ 2,
the probability to move into a deletion state is the same as the
probability to move into a duplication state. In a deletion/
duplication state, the underlying Markov chain has a default
probability 0.5 to revert back to cn¼ 2 and a probability 0.5
to remain in the same deletion/duplication state. To provide a
set of calls for each sample, we use the maximum likelihood
Viterbi algorithm. Each version of our statistical models in
Equations (1–3) generates a likelihood under the cn¼ 1, 2, 3
scenarios. For CNV with lower (cn¼ 0 for homozygous dele-
tion) or higher (cn  4) number of DNA copies, the model with
cn¼ 1, 2 and 3 hidden rejects the null with added confidence
compared with the simpler scenarios cn¼ 1 or cn¼ 3. Hence, we
found no benefit in considering additional copy number states
(besides, cn¼ 1, 2 and 3). Rather, we estimate copy number
state using the read count ratio after the CNV is detected.
Importantly, copy number is always estimated with respect to
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the reference and the absolute value cannot be estimated by this
procedure.
3.7 Power estimates
Owing to the common particular interest in discovering loss-of-
function variants we considered a heterozygous deletion as a
typical scenario for our power estimations (Fig. 2). The hetero-
zygous duplication case is considered in Supplementary Figure
S2. Following the parameter estimation step, we can generate for
each CNV, and given the test and reference read count data X
and Y, a Bayes factor BF¼PðX,Yjcn ¼ 1Þ=PðX,Yjcn ¼ 2Þ.
Using our selected prior distribution (P¼ 104 of observing a
CNV, i.e. corresponding to an expected number of 20 CNV
calls genome-wide), we compute the expected value of the pos-
terior distribution for the CNV call.
3.8 Choice of samples for the comparative analysis
We downloaded from the 1000 Genomes a dataset of 12
high-depth exome samples generated using the Solid sequencing
technology (single-end reads), for which an independent experi-
ment generated CNV calls using a high-density Nimblegen CGH
array (Conrad et al., 2010). These 12 samples are NA18502,
NA19099, NA19239, NA19240 (Yoruba) and NA06985,
NA1199, NA11995, NA12004, NA12044, NA12156, NA12414,
NA12489 (CEPH).
3.9 Parameters of ExomeCNV/exomeCopy in the
comparative analysis
To apply ExomeCNV we followed the instructions provided by
the user guide, using 0.9999 as threshold for sensitivity and spe-
cificity, with the software set to optimize the specificity. For each
test sample (labelled tumour sample in the ExomeCNV analysis),
the aggregegate reference set (labelled as normal) consisted of the
remaining exomes from the same dataset. We then applied the
classify.eCNV function with default parameters setting the ad-
mixture rate to 0 (because we are not concerned by a mixture
with tumour DNA). Finally, multi.CNV.analyze was used to
obtain the final list of merged calls from the list of exonic
CNV calls. For exomeCopy the read count data was estimated
using the R built-in functions provided by this package. For each
sample, the background noise was estimated on the basis of GC
content and the read count data from the other exomes in the
same dataset. We fitted the negative-binomial model and the
hidden Markov chain using the steps recommended in the pack-
age vignette and the default parameters. For the exomeCopy
analysis, the recommendation to split long exons into smaller
units (and therefore, get more uniform numbers of reads in
each bin) increased the number of CNV calls and the concord-
ance with DGV dropped, strongly suggesting that this step did
not improve the overall accuracy. We therefore used our set of
exon delimited regions to compute the read count.
4 DISCUSSION
We have developed a novel CNV calling methodology using read
depth information from exome sequence data and implemented
it within an R package called ExomeDepth. This allowed us to
maximize the statistical power to detect even small CNVs in the
presence of technical variability inherent to high-throughput
DNA sequencing technologies. As a consequence, compared
with other tools, we found the greatest improvement for datasets
that show more technical variability across samples. Although
ExomeDepth is designed to be used as a standalone software, the
contruction of a reference set is a problem shared across all read
depth CNV calling algorithms for exome data. Therefore, addi-
tional refinements proposed by other CNV calling algorithms to
improve calling accuracy could potentially be applied after
ExomeDepth has identified the optimum aggregate reference set.
Because ExomeDepth assumes that the CNV call is not pre-
sent in the reference sample, it is best suited to call rare CNVs.
Nevertheless, our analysis of exome samples from the 1000
Genome Project indicates that it can call common CNVs as
well, even though some power is lost when the allele frequency
is high. Our computations indicate that the power to detect rare
CNVs is maximized for a reference:test ratio of 10:1. Hence,
while we find no obvious benefit in using a very large dataset
(4100 exomes), it is essential to generate exome data in batches
of six or more samples.
Our analysis shows that a Gaussian model for the read count
data is not appropriate for exome sequence data, which is likely
to explain the discrepancy with the observed larger number of
CNV calls generated by ExomeCNV. The discrepancy with
exomeCopy is more surprising, because exomeCopy fits a
robust negative binomial model related to our model.
Additionally, in the exomeCopy analysis, we used the optimized
reference set identified by the ExomeDepth analysis. The default
parameters of the exomeCopy hidden Markov chain were also
similar. Comparing both methods, we find that the main differ-
ence is that exomeCopy essentially takes a profile likelihood ap-
proach: it uses the median normalized read depth at each exon to
account for the variability in exon capture efficiency, which is a
nuisance parameter. However, the median read depth can be
unreliable, if the sample size is small and/or the data are noisier
(e.g. in Dataset 2). Instead, in ExomeDepth we used a logistic
model, which deals with that nuisance parameter by conditioning
on the total read count for each exon. We hypothesize that
exomeCopy would show results more similar to ours, if the
exon-specific parameters were estimated within the negative
binomial model rather than prior to model fitting. However,
the number of exons, and therefore, the number of parameters
to estimate, would be large which makes it difficult in practice.
In our study the statistical power to detect CNVs varied
extensively between two datasets and was largely determined
by sample-to-sample variability within datasets that emerged
either at the exome capture or at the sequencing step. This fea-
ture of the data cannot be detected by commonly used
single-sample quality metrics: it is the correlations across samples
rather than the single-sample summary statistic that are relevant.
Owing to its essential role for CNV calling, we argue that a
measure of sample-to-sample consistency (e.g. correlation be-
tween FPKM values) should be provided by sequencing facilities
when exomes are analysed in sufficiently large batches.
Finding of the GATA2 and DOCK8 deletions illustrates the
power of ExomeDepth to identify even heterozygous and small
CNVs comprising just one to two exons. We conclude that redu-
cing technical variability between the samples and using
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bioinformatics tools that maximize statistical power of CNV de-
tection, such as ExomeDepth, will allow efficient CNV identifi-
cation and will increase the value of the future exome sequencing
experiments.
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